Vaccines against chikungunya, Zika and other emerging Aedes mosquito-borne viruses: unblocking existing bottlenecks. (November 2016)

• Record Type: Journal Article
• Authors: Rezza, Giovanni
• Is Part Of: Future virology. Volume 11:Number 11(2016)
• Page Start: 723
• Page End: 730
• Publication Date: 2016-11
• Subjects: arbovirus -- chikungunya -- neglected infections -- vaccine -- viral disease -- Yellow fever -- Zika; Virology -- Periodicals; Virus diseases -- Treatment -- Periodicals; 616.9101
• DOI: 10.2217/fvl-2016-0067
• Languages: English
• ISSNs: 1746-0794

Abstract

The emergence of Aedes mosquito-borne viral diseases is a global public health challenge. Since mosquito control programs are not highly efficient for outbreak containment, vaccines are essential to limit disease burden. Besides yellow fever vaccines, a vaccine against dengue is now available, while research on vaccines against Zika has just started. Several vaccine candidates against chikungunya are undergoing preclinical studies, and few of them have been tested in Phase II trials. To overcome hurdles and speed-up the development of vaccines against these viral diseases, several actions should be planned: first, the 'animal rule' could be considered for regulatory purposes; second, public–private partnership should be stimulated; third, countries, international organizations and donors commitment should be strengthened, and potential markets identified.